FR2922551B1 - Prodrogues phosphoesters de la gemcitabine comme agents anticancereux - Google Patents

Prodrogues phosphoesters de la gemcitabine comme agents anticancereux

Info

Publication number
FR2922551B1
FR2922551B1 FR0758386A FR0758386A FR2922551B1 FR 2922551 B1 FR2922551 B1 FR 2922551B1 FR 0758386 A FR0758386 A FR 0758386A FR 0758386 A FR0758386 A FR 0758386A FR 2922551 B1 FR2922551 B1 FR 2922551B1
Authority
FR
France
Prior art keywords
phosphoesters
gemcitabine
prodrugs
anticancer agents
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0758386A
Other languages
English (en)
Other versions
FR2922551A1 (fr
Inventor
Suzanne Peyrottes
Christian Perigaud
Charles Dumontet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Claude Bernard Lyon 1 UCBL
Universite Montpellier 2 Sciences et Techniques
Hospices Civils de Lyon HCL
Original Assignee
Universite Claude Bernard Lyon 1 UCBL
Universite Montpellier 2 Sciences et Techniques
Hospices Civils de Lyon HCL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Claude Bernard Lyon 1 UCBL, Universite Montpellier 2 Sciences et Techniques, Hospices Civils de Lyon HCL filed Critical Universite Claude Bernard Lyon 1 UCBL
Priority to FR0758386A priority Critical patent/FR2922551B1/fr
Priority to PCT/FR2008/051874 priority patent/WO2009053654A2/fr
Publication of FR2922551A1 publication Critical patent/FR2922551A1/fr
Application granted granted Critical
Publication of FR2922551B1 publication Critical patent/FR2922551B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0758386A 2007-10-17 2007-10-17 Prodrogues phosphoesters de la gemcitabine comme agents anticancereux Expired - Fee Related FR2922551B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0758386A FR2922551B1 (fr) 2007-10-17 2007-10-17 Prodrogues phosphoesters de la gemcitabine comme agents anticancereux
PCT/FR2008/051874 WO2009053654A2 (fr) 2007-10-17 2008-10-17 Prodrogues phosphoesters de la gemcitabine comme agents anticancereux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0758386A FR2922551B1 (fr) 2007-10-17 2007-10-17 Prodrogues phosphoesters de la gemcitabine comme agents anticancereux

Publications (2)

Publication Number Publication Date
FR2922551A1 FR2922551A1 (fr) 2009-04-24
FR2922551B1 true FR2922551B1 (fr) 2009-12-25

Family

ID=39203136

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0758386A Expired - Fee Related FR2922551B1 (fr) 2007-10-17 2007-10-17 Prodrogues phosphoesters de la gemcitabine comme agents anticancereux

Country Status (2)

Country Link
FR (1) FR2922551B1 (fr)
WO (1) WO2009053654A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0913677A2 (pt) * 2008-07-02 2015-12-15 Idenix Pharmaceuticals Inc composto, metabólito purificado, método para tratar um hospedeiro infectado com um vírus flaviviridade, composição farmacêutica, método para preparar o composto purificado, e, processo para preparar o composto
CN101525361B (zh) 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
WO2012154321A1 (fr) * 2011-03-31 2012-11-15 Idenix Pharmaceuticals, Inc. Composés et compositions pharmaceutiques pour le traitement d'infections virales
CN109956986B (zh) * 2017-12-22 2021-04-27 浙江柏拉阿图医药科技有限公司 肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) * 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds

Also Published As

Publication number Publication date
FR2922551A1 (fr) 2009-04-24
WO2009053654A3 (fr) 2009-08-20
WO2009053654A2 (fr) 2009-04-30

Similar Documents

Publication Publication Date Title
FR23C1051I1 (fr) 2'-fluoro-2'-desoxytetrahydrouridines comme inhibiteurs de cytidine desaminase
BRPI0922508A2 (pt) Análogos de nucleosídeo
LTC2203462I2 (lt) Nukleozidų fosforamidato provaistai
BRPI0810813A2 (pt) Agentes anti-hipertensivos de ação dupla
BRPI0810634A2 (pt) Composições fungicidas
DK2634232T3 (da) Sammensætninger
BRPI0814010A2 (pt) Composição de aço
BRPI0813533A2 (pt) Purificação de conjugado
BRPI0818079A2 (pt) composição de lipideo
BRPI0809314A2 (pt) Composições de tensoativo estruturado
BRPI0821714A2 (pt) Composições comestíveis
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
BRPI0815246A2 (pt) Composição de catalisador
BRPI0817444A2 (pt) Prímeres de poliunucleotídeo
BRPI0811132A2 (pt) Preparação de catalisadores de paládio-ouro
BRPI0919037A2 (pt) composições lubrificantes
BRPI0909189A2 (pt) combinações sinergísticas de 5'-metiltioadenosina
BRPI1010198A2 (pt) composição de poliamida modificada
BRPI0815473A2 (pt) Composições estruturadas de sabão
BRPI0908365A2 (pt) Paramixovírus antitumor efetivo
BRPI0814725A2 (pt) Composição antiviral
BRPI0908480A2 (pt) Composição de concentrado emulsionável
BRPI0906441A2 (pt) Composição de concentrado emulsificável
IT1393062B1 (it) Procedimento per la preparazione di gemcitabina cloridrato
FR2922551B1 (fr) Prodrogues phosphoesters de la gemcitabine comme agents anticancereux

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160630